Loic Falque

Days Alive and Out of Hospital Around Lung Transplantation: Predictors and Clinical Implications.

Journal: Chest

Published: April 16, 2026

Does the duration of exposure to everolimus influence the occurrence of chronic lung allograft dysfunction?

Journal: Transplant immunology

Published: March 19, 2026

Genome-wide association study reveals two novel genetic loci associated with chronic lung allograft dysfunction.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: October 28, 2025

Genome-wide association study reveals two novel genetic loci associated with chronic lung allograft dysfunction.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: October 28, 2025

Influence of tacrolimus concentration-to-dose ratio on CLAD risk in lung transplant recipients.

Journal: Transplant immunology

Published: October 21, 2025

Lung cancer after lung transplantation: Early detection and curative surgery drive long-term survival.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: September 25, 2025

Thrombotic Microangiopathy After Lung Transplantation: A Retrospective Observational Multicenter Cohort Study.

Journal: JHLT open

Published: July 30, 2025

Managing Cytomegalovirus Infection in Lung Transplant Recipients in Real Life: Results of a French Multicenter Survey.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: July 04, 2025

Effect of Donor Age on Survival in Lung Transplantation: A Multicentric Retrospective Study.

Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

Published: May 19, 2025

Nintedanib in progressive bronchiolitis obliterans syndrome (BOS) grade 0p-1-2 in lung transplant recipients (INFINITIx-BOS): protocol of a French multicenter randomized controlled trial.

Journal: Trials

Published: February 07, 2025

Days Alive and Out of Hospital Around Lung Transplantation: Predictors and Clinical Implications.

Days Alive and Out of Hospital Around Lung Transplantation: Predictors and Clinical Implications.

Does the duration of exposure to everolimus influence the occurrence of chronic lung allograft dysfunction?

Does the duration of exposure to everolimus influence the occurrence of chronic lung allograft dysfunction?

Genome-wide association study reveals two novel genetic loci associated with chronic lung allograft dysfunction.

Genome-wide association study reveals two novel genetic loci associated with chronic lung allograft dysfunction.

Genome-wide association study reveals two novel genetic loci associated with chronic lung allograft dysfunction.

Genome-wide association study reveals two novel genetic loci associated with chronic lung allograft dysfunction.

Influence of tacrolimus concentration-to-dose ratio on CLAD risk in lung transplant recipients.

Influence of tacrolimus concentration-to-dose ratio on CLAD risk in lung transplant recipients.

Lung cancer after lung transplantation: Early detection and curative surgery drive long-term survival.

Lung cancer after lung transplantation: Early detection and curative surgery drive long-term survival.

Thrombotic Microangiopathy After Lung Transplantation: A Retrospective Observational Multicenter Cohort Study.

Thrombotic Microangiopathy After Lung Transplantation: A Retrospective Observational Multicenter Cohort Study.

Managing Cytomegalovirus Infection in Lung Transplant Recipients in Real Life: Results of a French Multicenter Survey.

Managing Cytomegalovirus Infection in Lung Transplant Recipients in Real Life: Results of a French Multicenter Survey.

Effect of Donor Age on Survival in Lung Transplantation: A Multicentric Retrospective Study.

Effect of Donor Age on Survival in Lung Transplantation: A Multicentric Retrospective Study.

Nintedanib in progressive bronchiolitis obliterans syndrome (BOS) grade 0p-1-2 in lung transplant recipients (INFINITIx-BOS): protocol of a French multicenter randomized controlled trial.

Nintedanib in progressive bronchiolitis obliterans syndrome (BOS) grade 0p-1-2 in lung transplant recipients (INFINITIx-BOS): protocol of a French multicenter randomized controlled trial.

Trajectories of FEV1 after lung transplantation and patient outcomes.

Trajectories of FEV1 after lung transplantation and patient outcomes.

Is MUC5B rs35705950 promoter polymorphism associated with chronic lung allograft dysfunction?

Is MUC5B rs35705950 promoter polymorphism associated with chronic lung allograft dysfunction?